Maxmind is a Chinese pharmaceutical company vertically integrated R&D, producition and distribution in China with an international outlook.
Based on the unique understanding of China pharmaceutical market and the introduction ability of Multinational Companies’ technologies and products, Maxmind is integrating international and domestic resources by building a bridge linking China market and international innovations, using a higher perspective of analyzing technology and market to license in brands, patents or proprietary technologies from international pharmaceutical enterprises on the purpose of quality and management system improvement.
Adhering to the Philosophy of "Connecting Global Innovations with China Drive", Maxmind Pharma has been successfully cooperating with leading companies from Japan,Europe and India and has forged a strong portfolio of products with practical and innovative characteristics, and realized localized production of several products in China. Maxmind Pharma is also endeavoring in registering and marketing excellent Chinese products globally,such as plant-derived microsphere hemostatic powder.
2013
InMaxmind Pharma was established.
250
MillionThe registered capital of the group.
10
Member companies,rooted in China and linked to Japan, Europe and India, jointly building the value chain.
10
Cooperated original research drugs.
MEDICINE
Interacted with Government arms, Supported by think tanks and Reached to target terminals.
The group's 10 member companies radiate to domestic core areas such as Zhuhai and Hainan as well as overseas markets such as the European Union and Japan, building a cross-regional pharmaceutical industry collaborative network.
• Maxmind Bio-pharmaceutical (Zhuhai) Co., Ltd.
• Lucktin (Hainan) Biotechnology Co., Ltd.
• Shantou S.E.Z. Meiji Pharma Co., Ltd.
• Maxmind Biotechnology (Hainan) Co., Ltd.
• Jiangxi Meiji Pharma Co., Ltd.
• BYD Pharma (Hainan) Co., Ltd.
• Maxmind Pharma S.L.
• Maxmind Pharma Co., Ltd. (Osaka)
• Maxmind Pharma GmbH
• Onshindo Biotechnology S.L.